Germline BAP1 mutations predispose to malignant mesothelioma.

Area of Science:

• Oncology
• Genetics
• Cancer Research

Background:

• Malignant mesothelioma develops in a small fraction of asbestos-exposed individuals.
• Familial clustering of mesothelioma suggests a genetic predisposition.
• The role of genetic factors in mesothelioma and associated cancers requires further investigation.

Purpose of the Study:

• To identify genetic predisposing factors for malignant mesothelioma.
• To investigate the association between BRCA1 associated protein-1 (BAP1) gene mutations and cancer development.
• To characterize a potential BAP1-related cancer syndrome.

Main Methods:

• Germline and somatic mutation analysis of the BAP1 gene in familial and sporadic mesothelioma cases.
• Assessment of BAP1 expression levels.
• Clinical data review for associated cancers, including uveal melanoma.

Main Results:

• Germline BAP1 mutations were identified in families with high mesothelioma incidence.
• Somatic BAP1 alterations (biallelic inactivation) were observed in familial mesotheliomas.
• Germline BAP1 mutations were found in a subset of sporadic mesothelioma patients, some with a history of uveal melanoma.
• Somatic truncating BAP1 mutations and aberrant BAP1 expression were noted in sporadic mesotheliomas without germline mutations.
• A BAP1-related cancer syndrome characterized by mesothelioma and uveal melanoma was identified.

Conclusions:

• Germline and somatic mutations in BAP1 are implicated in the pathogenesis of mesothelioma.
• BAP1 mutations define a cancer predisposition syndrome associated with mesothelioma and uveal melanoma.
• Early identification of individuals with BAP1 mutations can facilitate targeted interventions for high-risk populations.